Report Description of the UK HIV Diagnostic Market Analysis
Research Scope and Assumption
- The report provides the market value for the base year 2020 and a yearly forecast up to 2028 in terms of revenue (USD billion)
- The key industry dynamics, regulatory scenario, reimbursement scenario, major market trends, and drug markets are evaluated to understand their impacts on the demand for the forecast period. The growth rates were estimated using correlation, regression, and time-series analysis
- We have used the combination of top-down and bottom-up approach for market sizing, analyzing key regional markets, dynamics, and trends for various solutions, services, and end uses
- All market estimates and forecasts have been validated through primary interviews with the Key Industry Players (KIPs) and secondary analysis
- Inflation has not been accounted for in order to estimate and forecast the market
- Numbers may not add up due to rounding off
Reason to buy the report:
- Facilitate decision-making based on strong current and forecast data for UK HIV Diagnostic Market Analysis
- Develop strategies based on the latest regulatory framework
- Strategically analyze micro-markets with respect to individual growth trends, future prospects, and their contribution to the market
- Analyze competitive developments such as expansions, investments, mergers & acquisitions, new product developments, and research & developments in the UK HIV Diagnostic Market Analysis
- Analyze the opportunities in the market for stakeholders and draw a competitive landscape for market leaders
- To strategically profile key players and comprehensively analyze their market shares and core competencies
- We have technically sound team which do a deep dive research and also provide strategy based consulting analysis
UK HIV Diagnostic Market Analysis Executive Summary
The United Kingdom (UK) has a relatively small, concentrated HIV epidemic, with an estimated 101,600 people living with HIV in 2017. This translates into an HIV prevalence of 1.7 per 1,000 people of all ages or 2.2 per 1,000 of people aged 15-74 years. In the same year, 4,363 people were newly diagnosed with HIV, a number that is steadily declining each year, falling by 17% between 2016 and 2017 alone. This is largely due to the decrease in new diagnoses among gay and bisexual men, the group most affected by HIV in the UK, which fell by almost a third (31%) between 2015 and 2017
Market Size and Key Findings
The UK HIV Diagnostic Market Analysis size stood at around USD xx billion in 2020 and is projected to reach USD xx billion by 2028, exhibiting a CAGR of xx% during the forecast period.
Market Growth Drivers Analysis
Pre-exposure prophylaxis (PrEP) is a daily course of antiretroviral drugs (ARVs) that can protect HIV-negative people from HIV. PrEP use in England is thought to have quadrupled during 2016 due to online purchasing among gay and bisexual men, which resulted in around 3,000 gay and bisexual men taking PrEP by the end of that year. In October 2017, a three-year PrEP trial began across 200 sexual health clinics in England, meaning it was then nationally available. Previously, the NHS in England had said that it could not PrEP, however this decision not was overturned in court. The last measure of needle and syringe programme (NSPs) coverage in the UK was in 2006. At the time, 80% of NSPs were pharmacy-based while the remainder were specialist centres. In 2014, National Institute for Health and Care Excellence (NICE) released new guidance on the provision of NSPs calling for a better mix of services. Opioid substitution therapy (OST) is widely available in the UK and tends to be dispensed by community-based pharmacists. In the UK, state schools have to provide sex and relationship education (SRE) but private schools do not. Parents also have the right to withdraw their children from SRE, though few do so. In the early years of the HIV epidemic, there were a number of high-profile awareness campaigns in the UK that warned the public about how HIV is transmitted and calling for people to adopt safer sex behaviours.
The ‘UK Stigma Index 2015’, a survey of more than 1,500 people living with HIV, found that a considerable number of people hold stigmatising attitudes towards those living with HIV. Around one in five people reported being excluded from family events because of their HIV status and 20% reported sexual rejection after telling someone their status. A third of all participants feared being rejected by a sexual partner (35%) and had avoided sexual encounters (33%) in the last 12 months due to their status. A new HIV Stigma Index survey is being carried out in 2019. There is also evidence that levels of HIV knowledge among the UK public is low. A survey by the National AIDS Trust in 2014 found that only 45% of people could correctly identify all of the ways HIV is and is not transmitted, and an increasing proportion incorrectly believed it can be transmitted via routes like kissing (16%). While HIV treatment was made free to people from overseas in 2012, many migrants living with HIV in the UK face other difficulties in accessing treatment, care and support. Undocumented migrants in particular find it difficult to register with a local General Practioner (GP): they are often required to prove their identity and do not understand NHS entitlement rules or how to apply for treatment.
COVID-19 impact on “UK HIV Diagnostic Market Analysis”
The year 2020 was dominated by the COVID – 19 pandemic as nearly two million people are infected by Coronavirus. On one hand, diagnostics, PPE equipment, critical medical supplies gained unprecedented demand while medical procedures declined by around 50% to 60% based on the market. The report presents the impact of the pandemic and recovery scenarios for HIV/AIDS Diagnostics over the forecast period to 2028. As companies realign their resources to operate under the limitations imposed by the pandemic, the report presents three scenarios of market recovery – Low Growth, Reference Case, and High Growth scenarios. The cases consider supply chain disruptions, consumer confidence, economic impact, and overall industry recovery factors.
Products in Pipeline
Projects included PROMOTE, which targeted male sex workers in Bristol through online outreach and peer-support groups, and a radio and podcast series for prisoners to dispel myths about HIV. Projects receiving funding between 2018 and 2019 include The Grass is Always Grindr, a weekly YouTube drama about a group of young gay men living in London, and Catwalks for Power, which aims to empower marginalized women living with HIV.
Notable Recent Deals
- In 2015, Public Health England began an HIV Prevention Innovation Fund to support community-led approaches to HIV prevention. Between 2017 and 2018 the fund reached around 170,000 people most affected by HIV in the UK.
Healthcare Policies and Regulatory Landscape
Policy changes and Reimbursement scenario
COVID-19 risks exacerbating the situation. WHO recently developed guidance for countries on how to safely maintain access to essential health services during the pandemic, including for all people living with or affected by HIV. The guidance encourages countries to limit disruptions in access to HIV treatment through “multi-month dispensing,” a policy whereby medicines are prescribed for longer periods of time – up to six months. To date, 129 countries have adopted this policy. Countries are also mitigating the impact of the disruptions by working to maintain flights and supply chains, engaging communities in the delivery of HIV medicines, and working with manufacturers to overcome logistics challenges..